DDI Drug Name |
DDI Drug ID |
Severity |
Mechanism |
Comorbidity |
REF |
Methylene blue |
DMJAPE7
|
Major |
Additive serotonergic effects by the combination of Meperidine and Methylene blue. |
Acquired methaemoglobinaemia [3A93]
|
[15] |
Oliceridine |
DM6MDCF
|
Major |
Additive CNS depression effects by the combination of Meperidine and Oliceridine. |
Acute pain [MG31]
|
[13] |
Marinol |
DM70IK5
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Marinol. |
Anorexia nervosa [6B80]
|
[16] |
Buspirone |
DMBS632
|
Major |
Additive serotonergic effects by the combination of Meperidine and Buspirone. |
Anxiety disorder [6B00-6B0Z]
|
[17] |
Methylphenobarbital |
DMDSWAG
|
Major |
Additive CNS depression effects by the combination of Meperidine and Methylphenobarbital. |
Anxiety disorder [6B00-6B0Z]
|
[18] |
Hydroxyzine |
DMF8Y74
|
Major |
Additive CNS depression effects by the combination of Meperidine and Hydroxyzine. |
Anxiety disorder [6B00-6B0Z]
|
[13] |
Halazepam |
DMPFWO6
|
Major |
Additive CNS depression effects by the combination of Meperidine and Halazepam. |
Anxiety disorder [6B00-6B0Z]
|
[13] |
Chlordiazepoxide |
DMTN5XI
|
Major |
Additive CNS depression effects by the combination of Meperidine and Chlordiazepoxide. |
Anxiety disorder [6B00-6B0Z]
|
[13] |
Chlormezanone |
DMTWUXR
|
Major |
Additive CNS depression effects by the combination of Meperidine and Chlormezanone. |
Anxiety disorder [6B00-6B0Z]
|
[13] |
Oxazepam |
DMXNZM4
|
Major |
Additive CNS depression effects by the combination of Meperidine and Oxazepam. |
Anxiety disorder [6B00-6B0Z]
|
[13] |
Desipramine |
DMT2FDC
|
Major |
Additive serotonergic effects by the combination of Meperidine and Desipramine. |
Attention deficit hyperactivity disorder [6A05]
|
[19] |
Linezolid |
DMGFPU2
|
Major |
Additive serotonergic effects by the combination of Meperidine and Linezolid. |
Bacterial infection [1A00-1C4Z]
|
[20] |
Retigabine |
DMGNYIH
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Retigabine. |
Behcet disease [4A62]
|
[16] |
Lamotrigine |
DM8SXYG
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Lamotrigine. |
Bipolar disorder [6A60]
|
[16] |
Cariprazine |
DMJYDVK
|
Major |
Additive CNS depression effects by the combination of Meperidine and Cariprazine. |
Bipolar disorder [6A60]
|
[13] |
Loperamide |
DMOJZQ9
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Loperamide. |
Bowel habit change [ME05]
|
[21] |
Alpelisib |
DMEXMYK
|
Moderate |
Increased metabolism of Meperidine caused by Alpelisib mediated induction of CYP450 enzyme. |
Breast cancer [2C60-2C6Y]
|
[22] |
Dihydrocodeine |
DMB0FWL
|
Major |
Additive CNS depression effects by the combination of Meperidine and Dihydrocodeine. |
Chronic pain [MG30]
|
[18] |
Levetiracetam |
DMTGDN8
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Levetiracetam. |
Chronic pain [MG30]
|
[16] |
Levobupivacaine |
DM783CH
|
Minor |
Increased plasma concentration of Meperidine and Levobupivacaine due to competitive binding of plasma proteins. |
Corneal disease [9A76-9A78]
|
[23] |
Propofol |
DMB4OLE
|
Moderate |
Additive cardiorespiratory depression effects by the combination of Meperidine and Propofol. |
Corneal disease [9A76-9A78]
|
[24] |
Ketamine |
DMT5HA4
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Ketamine. |
Corneal disease [9A76-9A78]
|
[16] |
Ethanol |
DMDRQZU
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Ethanol. |
Cystitis [GC00]
|
[25] |
Sertraline |
DM0FB1J
|
Major |
Additive serotonergic effects by the combination of Meperidine and Sertraline. |
Depression [6A70-6A7Z]
|
[19] |
Trimipramine |
DM1SC8M
|
Major |
Additive serotonergic effects by the combination of Meperidine and Trimipramine. |
Depression [6A70-6A7Z]
|
[19] |
Cyclobenzaprine |
DM1YBRM
|
Major |
Additive serotonergic effects by the combination of Meperidine and Cyclobenzaprine. |
Depression [6A70-6A7Z]
|
[17] |
Imipramine |
DM2NUH3
|
Major |
Additive serotonergic effects by the combination of Meperidine and Imipramine. |
Depression [6A70-6A7Z]
|
[19] |
Fluoxetine |
DM3PD2C
|
Major |
Additive serotonergic effects by the combination of Meperidine and Fluoxetine. |
Depression [6A70-6A7Z]
|
[19] |
Nortriptyline |
DM4KDYJ
|
Major |
Additive serotonergic effects by the combination of Meperidine and Nortriptyline. |
Depression [6A70-6A7Z]
|
[19] |
Vilazodone |
DM4LECQ
|
Major |
Additive serotonergic effects by the combination of Meperidine and Vilazodone. |
Depression [6A70-6A7Z]
|
[19] |
Nefazodone |
DM4ZS8M
|
Major |
Additive serotonergic effects by the combination of Meperidine and Nefazodone. |
Depression [6A70-6A7Z]
|
[19] |
Paroxetine |
DM5PVQE
|
Major |
Additive serotonergic effects by the combination of Meperidine and Paroxetine. |
Depression [6A70-6A7Z]
|
[19] |
Selegiline |
DM6034S
|
Major |
Additive serotonergic effects by the combination of Meperidine and Selegiline. |
Depression [6A70-6A7Z]
|
[15] |
Duloxetine |
DM9BI7M
|
Major |
Additive serotonergic effects by the combination of Meperidine and Duloxetine. |
Depression [6A70-6A7Z]
|
[19] |
Isocarboxazid |
DMAF1NB
|
Major |
Additive serotonergic effects by the combination of Meperidine and Isocarboxazid. |
Depression [6A70-6A7Z]
|
[15] |
Milnacipran |
DMBFE74
|
Major |
Additive serotonergic effects by the combination of Meperidine and Milnacipran. |
Depression [6A70-6A7Z]
|
[19] |
Escitalopram |
DMFK9HG
|
Major |
Additive serotonergic effects by the combination of Meperidine and Escitalopram. |
Depression [6A70-6A7Z]
|
[19] |
Tranylcypromine |
DMGB5RE
|
Major |
Additive serotonergic effects by the combination of Meperidine and Tranylcypromine. |
Depression [6A70-6A7Z]
|
[15] |
Desvenlafaxine |
DMHD4PE
|
Major |
Additive serotonergic effects by the combination of Meperidine and Desvenlafaxine. |
Depression [6A70-6A7Z]
|
[19] |
OPC-34712 |
DMHG57U
|
Major |
Additive CNS depression effects by the combination of Meperidine and OPC-34712. |
Depression [6A70-6A7Z]
|
[13] |
Phenelzine |
DMHIDUE
|
Major |
Additive serotonergic effects by the combination of Meperidine and Phenelzine. |
Depression [6A70-6A7Z]
|
[15] |
Clomipramine |
DMINRKW
|
Major |
Additive serotonergic effects by the combination of Meperidine and Clomipramine. |
Depression [6A70-6A7Z]
|
[19] |
Trazodone |
DMK1GBJ
|
Major |
Additive serotonergic effects by the combination of Meperidine and Trazodone. |
Depression [6A70-6A7Z]
|
[19] |
Amoxapine |
DMKITQE
|
Major |
Additive serotonergic effects by the combination of Meperidine and Amoxapine. |
Depression [6A70-6A7Z]
|
[19] |
Doxepin |
DMPI98T
|
Major |
Additive serotonergic effects by the combination of Meperidine and Doxepin. |
Depression [6A70-6A7Z]
|
[19] |
Maprotiline |
DMPWB7T
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Maprotiline. |
Depression [6A70-6A7Z]
|
[16] |
Esketamine |
DMVU687
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Esketamine. |
Depression [6A70-6A7Z]
|
[26] |
Mepenzolate |
DM8YU2F
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Mepenzolate. |
Digestive system disease [DE2Z]
|
[14] |
Oxybutynine |
DMJPBAX
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Oxybutynine. |
Discovery agent [N.A.]
|
[14] |
Heroin diacetylmorphine |
DMDBWHY
|
Major |
Additive CNS depression effects by the combination of Meperidine and Heroin diacetylmorphine. |
Dissociative neurological symptom disorder [6B60]
|
[18] |
Fenfluramine |
DM0762O
|
Major |
Additive serotonergic effects by the combination of Meperidine and Fenfluramine. |
Epilepsy/seizure [8A61-8A6Z]
|
[19] |
Diazepam |
DM08E9O
|
Major |
Additive CNS depression effects by the combination of Meperidine and Diazepam. |
Epilepsy/seizure [8A61-8A6Z]
|
[13] |
Zonisamide |
DM0DTF7
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Zonisamide. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Primidone |
DM0WX6I
|
Major |
Increased metabolism of Meperidine caused by Primidone mediated induction of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[21] |
Felbamate |
DM1V5ZS
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Felbamate. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Oxcarbazepine |
DM5PU6O
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Oxcarbazepine. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Mephenytoin |
DM5UGDK
|
Moderate |
Increased metabolism of Meperidine caused by Mephenytoin mediated induction of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[27] |
Gabapentin |
DM6T924
|
Major |
Additive CNS depression effects by the combination of Meperidine and Gabapentin. |
Epilepsy/seizure [8A61-8A6Z]
|
[28] |
Cenobamate |
DM8KLU9
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Cenobamate. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Tiagabine |
DMKSQG0
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Tiagabine. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Stiripentol |
DMMSDOY
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Stiripentol. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Phenacemide |
DMOHS9P
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Phenacemide. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Fosphenytoin |
DMOX3LB
|
Moderate |
Increased metabolism of Meperidine caused by Fosphenytoin mediated induction of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[27] |
Paramethadione |
DMR5ZUP
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Paramethadione. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Clonazepam |
DMTO13J
|
Major |
Additive CNS depression effects by the combination of Meperidine and Clonazepam. |
Epilepsy/seizure [8A61-8A6Z]
|
[13] |
Lacosamide |
DMVM6QR
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Lacosamide. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Rufinamide |
DMWE60C
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Rufinamide. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Ethotoin |
DMXWOCP
|
Moderate |
Increased metabolism of Meperidine caused by Ethotoin mediated induction of CYP450 enzyme. |
Epilepsy/seizure [8A61-8A6Z]
|
[27] |
Phenobarbital |
DMXZOCG
|
Major |
Additive CNS depression effects by the combination of Meperidine and Phenobarbital. |
Epilepsy/seizure [8A61-8A6Z]
|
[21] |
Vigabatrin |
DMYT0OG
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Vigabatrin. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Carbamazepine |
DMZOLBI
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Carbamazepine. |
Epilepsy/seizure [8A61-8A6Z]
|
[16] |
Cannabidiol |
DM0659E
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Cannabidiol. |
Epileptic encephalopathy [8A62]
|
[16] |
Dantrolene |
DM1D8XY
|
Major |
Additive CNS depression effects by the combination of Meperidine and Dantrolene. |
Fever [MG26]
|
[13] |
Solifenacin |
DMG592Q
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Solifenacin. |
Functional bladder disorder [GC50]
|
[14] |
Tolterodine |
DMSHPW8
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Tolterodine. |
Functional bladder disorder [GC50]
|
[14] |
Propantheline |
DM2EN6G
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Propantheline. |
Gastric ulcer [DA60]
|
[14] |
Cimetidine |
DMH61ZB
|
Moderate |
Decreased metabolism of Meperidine caused by Cimetidine mediated inhibition of CYP450 enzyme. |
Gastro-oesophageal reflux disease [DA22]
|
[29] |
Brimonidine |
DMQLT4N
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Brimonidine. |
Glaucoma [9C61]
|
[30] |
Isoniazid |
DM5JVS3
|
Moderate |
Additive hypotensive effects by the combination of Meperidine and Isoniazid. |
HIV-infected patients with tuberculosis [1B10-1B14]
|
[31] |
Procarbazine |
DMIK367
|
Major |
Additive serotonergic effects by the combination of Meperidine and Procarbazine. |
Hodgkin lymphoma [2B30]
|
[15] |
Suvorexant |
DM0E6S3
|
Major |
Additive CNS depression effects by the combination of Meperidine and Suvorexant. |
Insomnia [7A00-7A0Z]
|
[13] |
Ramelteon |
DM7IW9J
|
Major |
Additive CNS depression effects by the combination of Meperidine and Ramelteon. |
Insomnia [7A00-7A0Z]
|
[13] |
Flurazepam |
DMAL4G0
|
Major |
Additive CNS depression effects by the combination of Meperidine and Flurazepam. |
Insomnia [7A00-7A0Z]
|
[13] |
Triazolam |
DMETYK5
|
Major |
Additive CNS depression effects by the combination of Meperidine and Triazolam. |
Insomnia [7A00-7A0Z]
|
[13] |
Zaleplon |
DMGFWSM
|
Major |
Additive CNS depression effects by the combination of Meperidine and Zaleplon. |
Insomnia [7A00-7A0Z]
|
[13] |
Propiomazine |
DMKY8V1
|
Major |
Additive CNS depression effects by the combination of Meperidine and Propiomazine. |
Insomnia [7A00-7A0Z]
|
[13] |
Tasimelteon |
DMLOQ1V
|
Major |
Additive CNS depression effects by the combination of Meperidine and Tasimelteon. |
Insomnia [7A00-7A0Z]
|
[13] |
Paraldehyde |
DMOC1BX
|
Major |
Additive CNS depression effects by the combination of Meperidine and Paraldehyde. |
Insomnia [7A00-7A0Z]
|
[13] |
ITI-007 |
DMUQ1DO
|
Major |
Additive CNS depression effects by the combination of Meperidine and ITI-007. |
Insomnia [7A00-7A0Z]
|
[13] |
Nabilone |
DMVRYT2
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Nabilone. |
Insomnia [7A00-7A0Z]
|
[16] |
Quazepam |
DMY4D87
|
Major |
Additive CNS depression effects by the combination of Meperidine and Quazepam. |
Insomnia [7A00-7A0Z]
|
[13] |
Estazolam |
DMZGXUM
|
Major |
Additive CNS depression effects by the combination of Meperidine and Estazolam. |
Insomnia [7A00-7A0Z]
|
[13] |
Polyethylene glycol |
DM4I1JP
|
Moderate |
Increased risk of lowers seizure threshold by the combination of Meperidine and Polyethylene glycol. |
Irritable bowel syndrome [DD91]
|
[32] |
Clidinium |
DMUMQZ0
|
Moderate |
Additive antimotility effects by the combination of Meperidine and Clidinium. |
Irritable bowel syndrome [DD91]
|
[14] |
Dicyclomine |
DMZSDGX
|
Moderate |
Additive antimotility effects by the combination of Meperidine and Dicyclomine. |
Irritable bowel syndrome [DD91]
|
[14] |
Remimazolam |
DMLVSYX
|
Major |
Additive CNS depression effects by the combination of Meperidine and Remimazolam. |
Labour/delivery anaesthesia complication [JB0C]
|
[13] |
PF-06463922 |
DMKM7EW
|
Moderate |
Increased metabolism of Meperidine caused by PF-06463922 mediated induction of CYP450 enzyme. |
Lung cancer [2C25]
|
[26] |
Allopregnanolone |
DMNLHAC
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Allopregnanolone. |
Mental/behavioural/neurodevelopmental disorder [6E20-6E8Z]
|
[33] |
Dexmedetomidine |
DM93L4X
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Dexmedetomidine. |
Mood/affect symptom [MB24]
|
[16] |
Midazolam |
DMXOELT
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Midazolam. |
Mood/affect symptom [MB24]
|
[16] |
Thalidomide |
DM70BU5
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Thalidomide. |
Multiple myeloma [2A83]
|
[34] |
Prasugrel |
DM7MT6E
|
Moderate |
Altered absorption of Meperidine due to GI dynamics variation caused by Prasugrel. |
Myocardial infarction [BA41-BA43]
|
[35] |
Promethazine |
DM6I5GR
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Promethazine. |
Nausea/vomiting [MD90]
|
[16] |
Metoclopramide |
DMFA5MY
|
Moderate |
Antagonize the effect of Meperidine when combined with Metoclopramide. |
Nausea/vomiting [MD90]
|
[36] |
Granisetron |
DMIUW25
|
Major |
Additive serotonergic effects by the combination of Meperidine and Granisetron. |
Nausea/vomiting [MD90]
|
[37] |
Dolasetron |
DMMG26Z
|
Major |
Additive serotonergic effects by the combination of Meperidine and Dolasetron. |
Nausea/vomiting [MD90]
|
[37] |
Ondansetron |
DMOTQ1I
|
Major |
Additive serotonergic effects by the combination of Meperidine and Ondansetron. |
Nausea/vomiting [MD90]
|
[37] |
E-2007 |
DMJDYNQ
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and E-2007. |
Neuropathy [8C0Z]
|
[16] |
Bupropion |
DM5PCS7
|
Major |
Increased risk of lowers seizure threshold by the combination of Meperidine and Bupropion. |
Nicotine use disorder [6C4A]
|
[38] |
Sibutramine |
DMFJTDI
|
Major |
Additive serotonergic effects by the combination of Meperidine and Sibutramine. |
Obesity [5B80-5B81]
|
[39] |
Lorcaserin |
DMG6OYJ
|
Major |
Additive serotonergic effects by the combination of Meperidine and Lorcaserin. |
Obesity [5B80-5B81]
|
[40] |
Dexfenfluramine |
DMJ7YDS
|
Major |
Additive serotonergic effects by the combination of Meperidine and Dexfenfluramine. |
Obesity [5B80-5B81]
|
[19] |
Levomethadyl Acetate |
DM06HG5
|
Major |
Additive CNS depression effects by the combination of Meperidine and Levomethadyl Acetate. |
Opioid use disorder [6C43]
|
[18] |
Apraclonidine |
DMO4PVE
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Apraclonidine. |
Optic nerve disorder [9C40]
|
[30] |
Olaparib |
DM8QB1D
|
Moderate |
Increased metabolism of Meperidine caused by Olaparib mediated induction of CYP450 enzyme. |
Ovarian cancer [2C73]
|
[26] |
Safinamide |
DM0YWJC
|
Major |
Additive serotonergic effects by the combination of Meperidine and Safinamide. |
Parkinsonism [8A00]
|
[15] |
Rasagiline |
DM3WKQ4
|
Major |
Additive serotonergic effects by the combination of Meperidine and Rasagiline. |
Parkinsonism [8A00]
|
[15] |
Biperiden |
DME78OA
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Biperiden. |
Parkinsonism [8A00]
|
[41] |
Pimavanserin |
DMR7IVC
|
Major |
Additive CNS depression effects by the combination of Meperidine and Pimavanserin. |
Parkinsonism [8A00]
|
[13] |
Orphenadrine |
DMW542E
|
Major |
Additive CNS depression effects by the combination of Meperidine and Orphenadrine. |
Parkinsonism [8A00]
|
[13] |
Abametapir |
DM2RX0I
|
Moderate |
Decreased metabolism of Meperidine caused by Abametapir mediated inhibition of CYP450 enzyme. |
Pediculosis [1G00]
|
[42] |
Methylscopolamine |
DM5VWOB
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Methylscopolamine. |
Peptic ulcer [DA61]
|
[14] |
Levomepromazine |
DMIKFEL
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Levomepromazine. |
Psychotic disorder [6A20-6A25]
|
[16] |
Fluphenazine |
DMIT8LX
|
Major |
Additive CNS depression effects by the combination of Meperidine and Fluphenazine. |
Psychotic disorder [6A20-6A25]
|
[43] |
Triflupromazine |
DMKFQJP
|
Major |
Additive CNS depression effects by the combination of Meperidine and Triflupromazine. |
Psychotic disorder [6A20-6A25]
|
[13] |
Quetiapine |
DM1N62C
|
Major |
Additive CNS depression effects by the combination of Meperidine and Quetiapine. |
Schizophrenia [6A20]
|
[43] |
Mesoridazine |
DM2ZGAN
|
Major |
Additive CNS depression effects by the combination of Meperidine and Mesoridazine. |
Schizophrenia [6A20]
|
[43] |
Thioridazine |
DM35M8J
|
Major |
Additive CNS depression effects by the combination of Meperidine and Thioridazine. |
Schizophrenia [6A20]
|
[13] |
Aripiprazole |
DM3NUMH
|
Major |
Additive CNS depression effects by the combination of Meperidine and Aripiprazole. |
Schizophrenia [6A20]
|
[13] |
Iloperidone |
DM6AUFY
|
Major |
Additive CNS depression effects by the combination of Meperidine and Iloperidone. |
Schizophrenia [6A20]
|
[13] |
Paliperidone |
DM7NPJS
|
Major |
Additive CNS depression effects by the combination of Meperidine and Paliperidone. |
Schizophrenia [6A20]
|
[13] |
Haloperidol |
DM96SE0
|
Major |
Additive CNS depression effects by the combination of Meperidine and Haloperidol. |
Schizophrenia [6A20]
|
[13] |
Perphenazine |
DMA4MRX
|
Major |
Additive CNS depression effects by the combination of Meperidine and Perphenazine. |
Schizophrenia [6A20]
|
[13] |
Molindone |
DMAH70G
|
Major |
Additive CNS depression effects by the combination of Meperidine and Molindone. |
Schizophrenia [6A20]
|
[13] |
Chlorpromazine |
DMBGZI3
|
Major |
Additive CNS depression effects by the combination of Meperidine and Chlorpromazine. |
Schizophrenia [6A20]
|
[43] |
Thiothixene |
DMDINC4
|
Major |
Additive CNS depression effects by the combination of Meperidine and Thiothixene. |
Schizophrenia [6A20]
|
[43] |
Trifluoperazine |
DMKBYWI
|
Major |
Additive CNS depression effects by the combination of Meperidine and Trifluoperazine. |
Schizophrenia [6A20]
|
[13] |
Asenapine |
DMSQZE2
|
Major |
Additive CNS depression effects by the combination of Meperidine and Asenapine. |
Schizophrenia [6A20]
|
[13] |
Pimozide |
DMW83TP
|
Major |
Additive CNS depression effects by the combination of Meperidine and Pimozide. |
Schizophrenia [6A20]
|
[13] |
Fentanyl |
DM8WAHT
|
Major |
Additive CNS depression effects by the combination of Meperidine and Fentanyl. |
Sensation disturbance [MB40]
|
[13] |
Larotrectinib |
DM26CQR
|
Moderate |
Decreased metabolism of Meperidine caused by Larotrectinib mediated inhibition of CYP450 enzyme. |
Solid tumour/cancer [2A00-2F9Z]
|
[26] |
Fostamatinib |
DM6AUHV
|
Moderate |
Decreased clearance of Meperidine due to the transporter inhibition by Fostamatinib. |
Thrombocytopenia [3B64]
|
[44] |
Clopidogrel |
DMOL54H
|
Moderate |
Altered absorption of Meperidine due to GI dynamics variation caused by Clopidogrel. |
Thrombosis [DB61-GB90]
|
[35] |
Tizanidine |
DMR2IQ4
|
Major |
Additive CNS depression effects by the combination of Meperidine and Tizanidine. |
Tonus and reflex abnormality [MB47]
|
[13] |
Atropine |
DMEN6X7
|
Moderate |
Additive antimotility effects by the combination of Meperidine and Atropine. |
Unspecific substance harmful effect [NE6Z]
|
[14] |
Methdilazine |
DMAUHQX
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Methdilazine. |
Vasomotor/allergic rhinitis [CA08]
|
[16] |
Trimeprazine |
DMEMV9D
|
Moderate |
Additive CNS depression effects by the combination of Meperidine and Trimeprazine. |
Vasomotor/allergic rhinitis [CA08]
|
[45] |
----------- |
|
|
|
|
|